Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.

Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR.

Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.

2.

Is magnetic resonance safe in implanted cardiac devices patients?

Cernuschi G, Cringoli M; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2012 Jun;7(3):281-2. doi: 10.1007/s11739-012-0780-2. Epub 2012 Apr 11.

PMID:
22492008
3.

Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.

Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR.

Circulation. 2006 Sep 19;114(12):1277-84. Epub 2006 Sep 11.

4.

Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers.

Muehling OM, Wakili R, Greif M, von Ziegler F, Morhard D, Brueckmann H, Becker A.

J Cardiovasc Magn Reson. 2014 Jun 5;16:39. doi: 10.1186/1532-429X-16-39.

5.

Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.

Sheldon SH, Bunch TJ, Cogert GA, Acker NG, Dalzell CM, Higgins JV, Espinosa RE, Asirvatham SJ, Cha YM, Felmlee JP, Watson RE Jr, Anderson JL, Brooks MH, Osborn JS, Friedman PA.

Heart Rhythm. 2015 Feb;12(2):345-9. doi: 10.1016/j.hrthm.2014.11.037. Epub 2014 Nov 26.

PMID:
25433144
6.

A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).

Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C.

J Interv Card Electrophysiol. 2010 Jun;28(1):59-66. doi: 10.1007/s10840-009-9463-y. Epub 2010 Jan 29.

PMID:
20111895
7.

Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).

Kypta A, Blessberger H, Hoenig S, Saleh K, Lambert T, Kammler J, Fellner F, Lichtenauer M, Steinwender C.

J Magn Reson Imaging. 2016 Mar;43(3):574-84. doi: 10.1002/jmri.25037. Epub 2015 Sep 3.

PMID:
26335332
8.

Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.

Cohen JD, Costa HS, Russo RJ.

Am J Cardiol. 2012 Dec 1;110(11):1631-6. doi: 10.1016/j.amjcard.2012.07.030. Epub 2012 Aug 23.

PMID:
22921995
9.

Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience.

Goldsher D, Amikam S, Boulos M, Suleiman M, Shreiber R, Eran A, Goldshmid Y, Mazbar R, Roguin A.

Isr Med Assoc J. 2006 Feb;8(2):91-4.

10.

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.

Russo RJ, Costa HS, Silva PD, Anderson JL, Arshad A, Biederman RW, Boyle NG, Frabizzio JV, Birgersdotter-Green U, Higgins SL, Lampert R, Machado CE, Martin ET, Rivard AL, Rubenstein JC, Schaerf RH, Schwartz JD, Shah DJ, Tomassoni GF, Tominaga GT, Tonkin AE, Uretsky S, Wolff SD.

N Engl J Med. 2017 Feb 23;376(8):755-764. doi: 10.1056/NEJMoa1603265.

PMID:
28225684
11.

Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.

Bailey WM, Mazur A, McCotter C, Woodard PK, Rosenthal L, Johnson W, Mela T; ProMRI Study Investigators.

Heart Rhythm. 2016 Feb;13(2):464-71. doi: 10.1016/j.hrthm.2015.09.021. Epub 2015 Sep 25.

PMID:
26409098
12.

Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach.

Boilson BA, Wokhlu A, Acker NG, Felmlee JP, Watson RE Jr, Julsrud PR, Friedman PA, Cha YM, Rea RF, Hayes DL, Shen WK.

J Interv Card Electrophysiol. 2012 Jan;33(1):59-67. doi: 10.1007/s10840-011-9615-8. Epub 2011 Sep 21.

PMID:
21938517
14.

[Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].

Al-Sabagh KH, Christensen BE, Thøgersen AM, Petersen HH, Videbaek R, Pehrson S, Chen X, Thomsen C, Svendsen JH.

Ugeskr Laeger. 2010 Jun 7;172(23):1740-4. Danish.

PMID:
20534201
15.

"Power-on resets" in cardiac implantable electronic devices during magnetic resonance imaging.

Higgins JV, Sheldon SH, Watson RE Jr, Dalzell C, Acker N, Cha YM, Asirvatham SJ, Kapa S, Felmlee JP, Friedman PA.

Heart Rhythm. 2015 Mar;12(3):540-4. doi: 10.1016/j.hrthm.2014.10.039. Epub 2014 Nov 11.

PMID:
25460173
16.

Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla.

Gimbel JR.

Pacing Clin Electrophysiol. 2008 Jul;31(7):795-801. doi: 10.1111/j.1540-8159.2008.01117.x.

PMID:
18684275
17.

Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations.

Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H.

Circulation. 2006 Sep 19;114(12):1285-92. Epub 2006 Sep 11.

18.

Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study.

Wollmann CG, Thudt K, Kaiser B, Salomonowitz E, Mayr H, Globits S.

J Cardiovasc Magn Reson. 2014 May 6;16:30. doi: 10.1186/1532-429X-16-30.

19.

Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

20.

Summaries for patients. The safety of magnetic resonance imaging in patients with pacemakers or defibrillators.

[No authors listed]

Ann Intern Med. 2011 Oct 4;155(7):I34. doi: 10.7326/0003-4819-155-7-201110040-00002. No abstract available.

PMID:
21969352

Supplemental Content

Support Center